2008
DOI: 10.1002/chem.200801258
|View full text |Cite
|
Sign up to set email alerts
|

Antioxidant Activity of the Anti‐Inflammatory Compound Ebselen: A Reversible Cyclization Pathway via Selenenic and Seleninic Acid Intermediates

Abstract: A revised mechanism that accounts for the glutathione peroxidase (GPx)-like catalytic activity of the organoselenium compound ebselen is described. It is shown that the reaction of ebselen with H(2)O(2) yields seleninic acid as the only oxidized product. The X-ray crystal structure of the seleninic acid shows that the selenium atom is involved in a noncovalent interaction with the carbonyl oxygen atom. In the presence of excess thiol, the Se--N bond in ebselen is readily cleaved by the thiol to produce the cor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

13
161
0
1

Year Published

2011
2011
2018
2018

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 199 publications
(183 citation statements)
references
References 91 publications
13
161
0
1
Order By: Relevance
“…Ebselen is a synthetic organo-selenium compound (see the structure in Fig. 1) that exhibits antioxidant, antiinflammatory, and cytoprotective properties in a variety of animal models (Sakurai et al, 2006;Sarma and Mugesh, 2008). Moreover, unlike other selenium compounds, ebselen displays very low toxicity due to its great structural stability that does not allow the selenium moiety to be released during drug transformation and does not impair selenium metabolism (Sies and Masumoto, 1997;Zhao and Holmgren, 2002).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Ebselen is a synthetic organo-selenium compound (see the structure in Fig. 1) that exhibits antioxidant, antiinflammatory, and cytoprotective properties in a variety of animal models (Sakurai et al, 2006;Sarma and Mugesh, 2008). Moreover, unlike other selenium compounds, ebselen displays very low toxicity due to its great structural stability that does not allow the selenium moiety to be released during drug transformation and does not impair selenium metabolism (Sies and Masumoto, 1997;Zhao and Holmgren, 2002).…”
Section: Resultsmentioning
confidence: 99%
“…The chemistry of ebselen is considered complex and still controversial (see the viewpoints presented in Sakurai et al, 2006;Sarma and Mugesh, 2008). In fact, although, most of the biologic activities of ebselen seem to be related to its ability to quickly react with protein and nonprotein thiol groups, GSH included (Sakurai et al, 2006;Sarma and Mugesh, 2008), the details of these reactions remain obscure, mainly because of the lack of undisputed identification of the reaction intermediates.…”
Section: Anthracycline Reductive Metabolism In Human Heartmentioning
confidence: 99%
See 1 more Smart Citation
“…Similarly, in the DSP Cdc25 phosphatase B, a second cysteine resides in the active site, which in the oxidized form is disulfide-linked to the nucleophilic cysteine of the signature motif (51). In contrast, in PTP1B, the cysteine in the active site motif [I/V]HCxxGxxR[S/T] forms a cyclic sulfenyl-amide (419,495) in analogy to the redox cycle of the GPx mimic ebselen (423) (Fig. 3E).…”
Section: Brigelius-flohé and Flohémentioning
confidence: 99%
“…25,26 It is assumed that the most-studied GPx mimic ebselen (Nphenylbenzisoselenazo-3(2H)-one, 1), through the reaction with thiols, can be transformed to the corresponding diaryl diselenide with amido function 2 and in this form act as a bio-active intermediate that eliminates peroxides. [27][28][29] It has been proven that Se-N bond is not necessary to observe an enhanced GPx-like activity. Non-bonding selenium-heteroatom interactions can increase the antioxidant capacity what was established in the case of several diaryl diselenides possessing an additional heteroatom.…”
Section: Introductionmentioning
confidence: 99%